Sabine HOFF

Person

Potsdam, DE

People

Patents Grantslast 30 patents

Information Patent Grant
Methods of treatment using CCR8 antibodies
- Patent number 12,065,497
- Issue date Aug 20, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Grant
Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treatin...
- Patent number 11,951,166
- Issue date Apr 9, 2024
- Bayer Aktiengesellschaft
- Sabine Hoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treatin...
- Patent number 11,517,622
- Issue date Dec 6, 2022
- Bayer HealthCare LLC
- Sabine Hoff
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Grant
CCR8 antibodies for therapeutic applications
- Patent number 11,427,640
- Issue date Aug 30, 2022
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING

Patents Applicationslast 30 patents

Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240400700
- Publication date Dec 5, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- G01 - MEASURING TESTING
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20240376218
- Publication date Nov 14, 2024
- Bayer Aktiengesellschaft
- Sandra Berndt
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION
- Publication number 20230250178
- Publication date Aug 10, 2023
- Bayer Aktiengesellschaft
- Sandra BERNDT
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS
- Publication number 20220363768
- Publication date Nov 17, 2022
- Bayer Aktiengesellschaft
- Sandra Berndt
- C07 - ORGANIC CHEMISTRY
Information Patent Application
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...
- Publication number 20220133888
- Publication date May 5, 2022
- Bayer Aktiengesellschaft
- Sabine HOFF
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...
- Publication number 20200188372
- Publication date Jun 18, 2020
- Bayer Aktiengesellschaft
- Sabine HOFF
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...
- Publication number 20200179354
- Publication date Jun 11, 2020
- Bayer Aktiengesellschaft
- Sabine HOFF
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE
Information Patent Application
COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...
- Publication number 20200155674
- Publication date May 21, 2020
- Bayer Aktiengesellschaft
- Sabine HOFF
- A61 - MEDICAL OR VETERINARY SCIENCE HYGIENE

Sabine HOFF

Person

Patents Grantslast 30 patents

Methods of treatment using CCR8 antibodies

Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treatin...

Combination of regorafenib and PD-1/PD-L1(2) inhibitors for treatin...

CCR8 antibodies for therapeutic applications

Patents Applicationslast 30 patents

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

SULFATED PEPTIDES FOR CHEMOKINE RECEPTOR ANTIBODY GENERATION

CCR8 ANTIBODIES FOR THERAPEUTIC APPLICATIONS

COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...

COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...

COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...

COMBINATION OF REGORAFENIB AND PD-1/PD-L1(2) INHIBITORS FOR TREATIN...